REVIEW
Published on 24 Jan 2024
Clinical research on RSV prevention in children and pregnant women: progress and perspectives
doi 10.3389/fimmu.2023.1329426
- 2,788 views
- 3 citations
- Frontiers in Immunology
- Vaccines and Molecular Therapeutics
- Research Topics
- Overcoming Challenges in Vaccines and Molecular Therapeutics: 2022
Overcoming Challenges in Vaccines and Molecular Therapeutics: 2022
12k
Total downloads
47k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 08 Dec 2023
Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern
doi 10.3389/fimmu.2023.1307693
- 1,726 views
- 3 citations
REVIEW
Published on 27 Nov 2023
Analysis of the protective efficacy of approved COVID-19 vaccines against Omicron variants and the prospects for universal vaccines
doi 10.3389/fimmu.2023.1294288
- 3,109 views
- 3 citations
REVIEW
Published on 03 Nov 2023
Side effects of COVID-19 vaccines in the middle eastern population
doi 10.3389/fimmu.2023.1270187
- 4,858 views
ORIGINAL RESEARCH
Published on 05 Oct 2023
Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer
doi 10.3389/fimmu.2023.1260195
- 1,829 views
- 2 citations
CLINICAL TRIAL
Published on 18 Sep 2023
Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial
doi 10.3389/fimmu.2023.1241153
- 1,268 views
- 3 citations
ORIGINAL RESEARCH
Published on 02 Jun 2023
Increasing human monoclonal antibody cloning efficiency with a whole-cell modified immunoglobulin-capture assay (mICA)
doi 10.3389/fimmu.2023.1184510
- 2,426 views
REVIEW
Published on 02 Jun 2023
Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement
doi 10.3389/fimmu.2023.1200195
- 12,958 views
- 20 citations
ORIGINAL RESEARCH
Published on 19 May 2023
A tetravalent nanoparticle vaccine elicits a balanced and potent immune response against dengue viruses without inducing antibody-dependent enhancement
doi 10.3389/fimmu.2023.1193175
- 3,852 views
- 7 citations
HYPOTHESIS AND THEORY
Published on 26 Apr 2023
Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors
doi 10.3389/fimmu.2023.1183258
- 3,239 views
- 10 citations
ORIGINAL RESEARCH
Published on 21 Apr 2023
A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection
doi 10.3389/fimmu.2023.1182963
- 2,834 views
- 7 citations
ORIGINAL RESEARCH
Published on 20 Mar 2023
Protection from COVID-19 disease in hamsters vaccinated with subunit SARS-CoV-2 S1 mucosal vaccines adjuvanted with different adjuvants
doi 10.3389/fimmu.2023.1154496
- 1,706 views
- 4 citations
Published in
Frontiers in Immunology
- Vaccines and Molecular Therapeutics
Participating Journals
Frontiers in Public Health
Vaccines and Molecular TherapeuticsOffline
- 3.0 impact factor
- 4.8 citescore
Impact
- 47kTopic views
- 34kArticle views
- 12kArticle downloads